Literature DB >> 10725481

Determinants of long-term hormone replacement therapy and reasons for early discontinuation.

I den Tonkelaar1, B J Oddens.   

Abstract

OBJECTIVE: To identify factors associated with long-term hormone replacement therapy (HRT) and reasons for early discontinuation of it.
METHODS: A cross-sectional study was conducted in four United Kingdom group general practices. Six hundred fifteen past or present HRT users (representing a response rate of 66%) responded to questionnaires on HRT and potential determinants of long-term use. Main outcome measures were long-term HRT use (at least 6 years) as opposed to short-term use (at most 2 years) and self-reported reasons for discontinuation. Odds ratios (ORs) of long-term use were adjusted for age and other variables, in the same groups, calculated by logistic regression and 95% confidence intervals (CIs).
RESULTS: Ovariectomy (OR 2.59, 95% CI 1.12, 5.97), hysterectomy (OR 2.28, 95% CI 1.37, 3.79), previous oral contraceptive use (OR 1.76, 95% CI 1. 03, 3.01), HRT prescription to prevent osteoporosis (OR 1.81, 95% CI 1.04, 3.13), opinion that HRT prevents health problems (OR 3.22, 95% CI 1.57, 6.63), opinion that HRT is associated with health risks (OR 0.23, 95% CI 0.08, 0.65), and opinion that HRT has cosmetic benefits (OR 2.52, 95% CI 1.45, 4.40) were statistically significantly associated with long-term HRT. Women surveyed most often reported side effects and weight gain (each about 30%) as reasons for discontinuation, followed by possible health risks and dislike of menstrual bleeding or hormones (each about 15%).
CONCLUSION: Ovariectomy, hysterectomy, and opinions about benefits and disadvantages of HRT were the most important determinants of long-term use, whereas women themselves mentioned side effects and weight gain most frequently as reasons for discontinuing it.

Entities:  

Mesh:

Year:  2000        PMID: 10725481     DOI: 10.1016/s0029-7844(99)00586-4

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

Review 1.  Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis.

Authors:  S A Atkinson; W E Ward
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

2.  Incidence and causes for failure of treatment of women with proven osteoporosis.

Authors:  Noah Zafran; Zvi Liss; Ronit Peled; Michael Sherf; Haim Reuveni
Journal:  Osteoporos Int       Date:  2005-04-02       Impact factor: 4.507

3.  Timing of hormone therapy and dementia: the critical window theory revisited.

Authors:  Rachel A Whitmer; Charles P Quesenberry; Jufen Zhou; Kristine Yaffe
Journal:  Ann Neurol       Date:  2010-11-12       Impact factor: 10.422

4.  Predictors of compliance with a home-based exercise program added to usual medical care in preventing postmenopausal osteoporosis: an 18-month prospective study.

Authors:  M A Mayoux-Benhamou; C Roux; A Perraud; J Fermanian; H Rahali-Kachlouf; M Revel
Journal:  Osteoporos Int       Date:  2004-07-29       Impact factor: 4.507

5.  Initiation and discontinuation of hormone therapy for menopausal symptoms: results from a community sample.

Authors:  Hayden B Bosworth; Lori A Bastian; Steven C Grambow; Colleen M McBride; Celette Sugg Skinner; Laura Fish; Barbara K Rimer; Ilene C Siegler
Journal:  J Behav Med       Date:  2005-02

Review 6.  Patient adherence to osteoporosis medications: problems, consequences and management strategies.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; Lisa Dolovich; Elaine Lau; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

7.  Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone.

Authors:  Pearl L Breitman; Debbie Fonseca; Angela M Cheung; Wendy E Ward
Journal:  Bone       Date:  2003-10       Impact factor: 4.398

8.  Compliance with pharmacologic therapy for osteoporosis.

Authors:  Robert A Yood; Srinivas Emani; John I Reed; Barbara Edelman Lewis; Mary Charpentier; Eva Lydick
Journal:  Osteoporos Int       Date:  2003-09-19       Impact factor: 4.507

Review 9.  Non-compliance: the Achilles' heel of anti-fracture efficacy.

Authors:  E Seeman; J Compston; J Adachi; M L Brandi; C Cooper; B Dawson-Hughes; B Jönsson; H Pols; J A Cramer
Journal:  Osteoporos Int       Date:  2007-01-24       Impact factor: 5.071

Review 10.  Abnormal bleeding during menopause hormone therapy: insights for clinical management.

Authors:  Sebastião Freitas de Medeiros; Márcia Marly Winck Yamamoto; Jacklyne Silva Barbosa
Journal:  Clin Med Insights Womens Health       Date:  2013-01-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.